Oscar Kuruvilla, MD
Ophthalmology · Lancaster, SCNPI 1861711558
Payments from drug & device makers
Across 294 payments — averaging $41.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$7K
- Johnson & Johnson Surgical Vision, Inc.$1K
- Astellas Pharma US Inc$882
- AbbVie$668
- Bausch & Lomb Americas Inc.$442
- Bausch & Lomb, A Division Of Bausch Health US, LLC$383
- plus $1K from 16 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 149 | $7,362 |
| Johnson & Johnson Surgical Vision, Inc. | 22 | $1,086 |
| Astellas Pharma US Inc | 18 | $882 |
| AbbVie(2 entities) | 30 | $668 |
| Bausch & Lomb Americas Inc. | 18 | $442 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $383 |
| Notal Vision, Inc. | 4 | $284 |
| Genentech USA, Inc. | 12 | $221 |
| Mallinckrodt Hospital Products Inc. | 4 | $169 |
| Regeneron Healthcare Solutions, Inc. | 7 | $134 |
| Staar Surgical Company | 2 | $101 |
| Dompe US, Inc. | 3 | $78 |
| Rayner Intraocular Lenses Limited | 3 | $47 |
| Ocular Therapeutix, Inc. | 2 | $45 |
| Apellis Pharmaceuticals, Inc. | 2 | $42 |
| Aerie Pharmaceuticals, Inc. | 2 | $33 |
| Omeros Corporation | 2 | $33 |
| Novartis | 2 | $32 |
| Glaukos Corporation | 1 | $22 |
| Harrow Eye, LLC | 1 | $18 |
| Oyster Point Pharma, Inc. | 1 | $17 |
| Kala Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$12,115 in reported general payments places this provider in the 85th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Lancaster
- John WellsWest Columbia$7.1M
- William ClarkWest Columbia$6.2M
- Daniel AlfaroCharleston$4.6M
- Kerry SolomonMt Pleasant$4.6M
- Eric JablonCharleston$1.2M
- George WaringMt Pleasant$1M
- John KerrisonCharleston$975K
- Karolinne RochaCharleston$799K
- John PayneWest Columbia$574K
- Mona CamacciCharleston$534K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.